[HTML][HTML] Recent advances and limitations of mTOR inhibitors in the treatment of cancer

ES Ali, K Mitra, S Akter, S Ramproshad, B Mondal… - Cancer cell …, 2022 - Springer
Abstract The PI3K-Akt-mechanistic (formerly mammalian) target of the rapamycin (mTOR)
signaling pathway is important in a variety of biological activities, including cellular …

[HTML][HTML] Precision drugging of the MAPK pathway in head and neck cancer

HL Ngan, CH Law, YCY Choi, JYS Chan… - NPJ genomic …, 2022 - nature.com
The mitogen-activating protein kinase (MAPK) pathway is central for cell proliferation,
differentiation, and senescence. In human, germline defects of the pathway contribute to …

Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma

S Badodi, N Pomella, YM Lim, S Brandner… - Neuro …, 2022 - academic.oup.com
Background Epigenetic changes play a key role in the pathogenesis of medulloblastoma
(MB), the most common malignant pediatric brain tumor. Methods We explore the …

[HTML][HTML] Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic …

L Jing, Y Du, D Fu - Frontiers in Genetics, 2022 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) represents one of the most prevalent
and malignant tumors of epithelial origins with unfavorable outcomes. Increasing evidence …

Advances in autophagy as a target in the treatment of tumours

Y Li, S Gao, X Du, J Ji, Y Xi, G Zhai - Journal of Drug Targeting, 2022 - Taylor & Francis
Autophagy is a multi-step lysosomal degradation process, which regulates energy and
material metabolism and has been used to maintain homeostasis. Autophagy has been …

Precision drugging of the MAPK pathway in head and neck cancer

N Hoi-Lam, L Chun-Ho, CYC Yan… - NPJ Genomic …, 2022 - search.proquest.com
The mitogen-activating protein kinase (MAPK) pathway is central for cell proliferation,
differentiation, and senescence. In human, germline defects of the pathway contribute to …

Novel mTOR inhibitors: Promising therapeutic interventions in oral cancer therapy

D Ezhilarasan, KS Harini - Oral oncology, 2022 - pubmed.ncbi.nlm.nih.gov
Novel mTOR inhibitors: Promising therapeutic interventions in oral cancer therapy Novel mTOR
inhibitors: Promising therapeutic interventions in oral cancer therapy Oral Oncol. 2022 …